Maximus, Inc. (NYSE:MMS) Stock Position Raised by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale grew its position in Maximus, Inc. (NYSE:MMS - Free Report) by 501.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,100 shares of the health services provider's stock after purchasing an additional 35,100 shares during the quarter. DekaBank Deutsche Girozentrale owned approximately 0.07% of Maximus worth $3,511,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. VisionPoint Advisory Group LLC lifted its holdings in Maximus by 61.4% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider's stock worth $28,000 after buying an additional 145 shares during the last quarter. Farther Finance Advisors LLC boosted its holdings in Maximus by 71.7% in the second quarter. Farther Finance Advisors LLC now owns 352 shares of the health services provider's stock valued at $30,000 after purchasing an additional 147 shares in the last quarter. Anchor Investment Management LLC purchased a new position in Maximus in the fourth quarter valued at approximately $32,000. Macquarie Group Ltd. acquired a new stake in Maximus during the first quarter worth approximately $35,000. Finally, Planned Solutions Inc. purchased a new stake in shares of Maximus during the 4th quarter worth approximately $59,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

MMS has been the topic of a number of recent analyst reports. Raymond James downgraded shares of Maximus from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 3rd. StockNews.com raised Maximus from a "hold" rating to a "buy" rating in a report on Thursday, February 8th.

Maximus Stock Performance

NYSE MMS traded down $0.30 on Friday, reaching $80.00. The stock had a trading volume of 252,255 shares, compared to its average volume of 262,018. The stock has a market cap of $4.88 billion, a P/E ratio of 26.49 and a beta of 0.72. Maximus, Inc. has a 12-month low of $72.39 and a 12-month high of $89.69. The business's 50-day moving average price is $82.58 and its 200 day moving average price is $80.94. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.69 and a current ratio of 1.69.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, beating the consensus estimate of $1.28 by $0.06. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 3.73% and a return on equity of 15.68%. Maximus's revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.94 EPS. As a group, equities analysts expect that Maximus, Inc. will post 5.41 earnings per share for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date of this dividend is Tuesday, May 14th. Maximus's payout ratio is currently 39.74%.

Insider Activity

In related news, CFO David Mutryn sold 8,000 shares of the company's stock in a transaction on Friday, February 16th. The stock was sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the transaction, the chief financial officer now directly owns 5,124 shares in the company, valued at $430,159.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.40% of the company's stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.